Mercaptamine
Mercaptamine is an approved active ingredient.
Chemical compound
What it is used for
- Cystinosis
- Corneal deposit
- Eye disease
PROCYSBI is indicated for the treatment of nephropathic cystinosis in adults and pediatric patients 1 year of age and older. PROCYSBI is a cystine-depleting agent indicated for the treatment of nephropathic cystinosis in adults and pediatric patients 1 year of age and older.
Cystagon is indicated for the treatment of proven nephropathic cystinosis.
How it works
- Cystine reducing agent
Common side effects
The following adverse reactions are also discussed in other sections of the labeling: Ehlers-Danlos-like Syndrome Skin Rash Gastrointestinal (GI) Ulcers and Bleeding Fibrosing Colonopathy Central Nervous System Symptoms Leukopenia and/or Elevated Phosphatase Levels Benign Intracranial Hypertension Most common adverse…
Who should not take it
The use of PROCYSBI is contraindicated in patients with a serious hypersensitivity reaction, including anaphylaxis, to penicillamine or cysteamine.
Pregnancy and breastfeeding
There are no available data on PROCYSBI use in pregnant women to inform any drug-associated risks for birth defects or miscarriage.
Brand names
United States
Cystadrops · Cystagon · Cystaran · Procysbi
European Union
Cystadrops · Cystagon · Procysbi
Canada
Cysklar · Cystadrops · Procysbi
Approval status
- US Food and Drug Administration
- prescription · since 1994
- European Medicines Agency
- authorised · since 1997
- Health Canada
- prescription · marketed
- First approval anywhere
- 1994
Codes
- ATC
- A16AA04, S01XA21
- RxNorm CUI
- 3022
- ChEMBL
- CHEMBL602
- PubChem CID
- 118985556
- UNII
- 5UX2SD1KE2
- Wikidata
- Q617563
Frequently asked questions
What is Mercaptamine used for?
Mercaptamine is used for: Cystinosis, Corneal deposit, and Eye disease.
What are the brand names of Mercaptamine?
Brand names of Mercaptamine include Cystadrops, Cystagon, Cystaran, Procysbi, and Cysklar.
Medicines in the same class
- Ascorbic acid
- Sodium chloride
- Riboflavin
- Potassium iodide
- Acetylcysteine
- Retinol
- Ciclosporin
- Sirolimus
- Varenicline
- Alteplase
Sources and licences
- ChEMBL (CC BY-SA 3.0)
- Wikidata (CC0 1.0)
- openFDA / DailyMed (public domain)
- European Medicines Agency (reuse with acknowledgement)
- Health Canada Drug Product Database (Open Government Licence – Canada)